| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2014-10-14 | EnanDIM technology | Mologen (Germany) | Cancer - Oncology - Infectious diseases | ||
| 2014-10-14 | tetravalent rotavirus vaccine candidate | rotavirus gastroenteritis |
3 | Shantha Biotechnics (India) Sanofi Pasteur (France) | Infectious diseases |
| 2014-10-14 | RhoNova™ (GT038) adeno-associated viral vector containing DNA encoding an RNAi targeting rhodopsin in combination with an adeno-associated viral vector containing DNA encoding a rhodopsin gene | retinitis pigmentosa | Genable Technologies (Ireland) | Rare diseases - Genetic diseases - Ophtalmological diseases | |
| 2014-10-14 | Brisdelle® (paroxetine) | moderate to severe hot flashes associated with menopause |
3 | Noven Pharmaceuticals (USA - FL) | Women health |
| 2014-10-14 | ALN-TTRsc | TTR-mediated amyloidosis (ATTR) |
1 | Alnylam Pharmaceuticals (USA - MA) | Rare diseases - Genetic diseases |
| 2014-10-13 | Perceval valve | aortic valve replacement |
Sorin (Italy) | Cardiovascular diseases | |
| 2014-10-10 | Decapeptyl® (triptorelin pamoate) 11.25 mg | locally advanced or metastatic prostate cancer |
3 | Ipsen (France) | Cancer - Oncology |
| 2014-10-10 | secukinumab (AIN457) | psoriasis |
3 | Novartis (Switzerland) | Autoimmune diseases - Dermatological diseases |
| 2014-10-10 | 4-antigen Staphylococcus aureus candidate vaccine (SA4Ag) | Staphylococcus aureus infection |
1-2 | Pfizer (USA - NY) | Infectious diseases |
| 2014-10-10 | |||||
| 2014-10-10 | EPZ-5676 | acute lymphoblastic leukemia (ALL) acute myeloid leukemia (AML) |
1 | Epizyme (USA - MA) | Cancer - Oncology |
| 2014-10-10 | Belviq® (lorcaserin hydrochloride) | chronic weight management |
3 | Eisai (Japan) Arena Pharmaceuticals (USA - CA) | Metabolic diseases |
| 2014-10-09 | Orbactiv™ (oritavancin) | acute bacterial skin and skin structure infections (ABSSSI) |
3 | The Medicines Company (USA - NJ) | Infectious diseases |
| 2014-10-09 | sapacitabine | acute myeloid leukemia | 3 | Cyclacel Pharmaceuticals (USA - NJ) | Cancer - Oncology |
| 2014-10-09 | VX-661 ( tezacaftor) in combination with ivacaftor | cystic fibrosis | 2 | Vertex Pharmaceuticals (USA - MA) | Rare diseases - Genetic diseases |
| 2014-10-09 | Kalydeco® (ivacaftor) | cystic fibrosis | 3 | Vertex Pharmaceuticals (USA - MA) | Rare diseases - Genetic diseases |
| 2014-10-09 | Tiara™ transcatheter mitral valve | OPKO Health (USA - FL) Neovasc (Canada) | Cardiovascular diseases | ||
| 2014-10-09 | Actimmune® (interferon gamma-1b) | Friedreich\'s Ataxia |
2 | Horizon Pharma (Ireland) | Rare diseases - Neurodegenerative diseases |
| 2014-10-09 | veliparib (ABT-888) | non-squamous non-small cell lung cancer | 3 | Abbvie (USA - IL) | Cancer - Oncology |
| 2014-10-09 | benralizumab | severe asthma |
2b | AstraZeneca (UK) | Allergic diseases - Inflammatory diseases - Respiratory diseases |
